Medial artery calcification (MAC) in transcatheter arterialization of deep veins (TADV)

Read full text Summarise with VIRAT
Authors: Mounika Naidu Boya, Michael Cyrus Siah, Sara Rose-Sauld, Adriana Araceli Rodriguez Alvarez, Isabella Ferlini Cieri, Shiv S. Patel, Roberto Ferraresi, Anahita Dua
Cited by: 0
References: 16

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective Transcatheter arterialization of the deep veins (TADV) is an emerging option for patients with no-option chronic limb-threatening ischemia (CLTI). While promising for limb salvage, predictors of outcomes remain undefined. Medial arterial calcification (MAC) is common in this population and may influence procedural success and healing, but its role in the TADV setting is not well established. We aimed to evaluate the clinical outcomes of TADV in no-option CLTI patients and explore the utility of preoperative pedal MAC scores. Methods A retrospective analysis of 28 patients (30 limbs) with no-option CLTI who underwent TADV between 2020 and 2024 across two tertiary centers was done. Preoperative MAC burden was quantified using foot X-rays and categorized as MAC > 3 vs. MAC ≤ 3. Primary outcomes included limb salvage and overall survival; secondary outcomes included wound healing, minor amputations, and length of hospital stay. Kaplan-Meier analyses were used to estimate survival and stratify outcomes by MAC burden. Results Mean age was 63.1 ± 12.3 years; 75 % were male, 92.9 % had diabetes, and 75 % had chronic kidney disease. The median baseline MAC score was 4.0 (IQR 3.0–5.0), with 53.3 % of limbs classified as MAC > 3. At 6 months, limb salvage and amputation-free survival were 86.5 % and 81.1 %, respectively. Over half of the limbs achieved complete wound healing. Patients with MAC > 3 had numerically higher 6-month limb salvage (90.9 % vs. 82.5 %) and survival (100 % vs. 91.7 %) compared to MAC ≤ 3, though differences were not statistically significant. Conclusions TADV may be a viable limb salvage strategy for patients with no-option CLTI, achieving high wound healing and survival rates despite advanced comorbid burden and MAC scores. MAC scoring may assist in risk stratification, but larger prospective studies are needed to validate its prognostic utility in TADV-treated patients.

Fields of Study & Subjects

Peripheral Artery Disease Management Vascular Procedures and Complications Central Venous Catheters and Hemodialysis

Publication details

Journal / source
Annals of Vascular Surgery - Brief Reports and Innovations
Volume
6
Issue
2
Pages
100445–100445
Publication date
24 March 2026
Language
EN